vTv Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$3.20 | -$3.20 | -$3.20 |
| Q2 2024 | 0 | -$3.20 | -$3.20 | -$3.20 |
| Q3 2024 | 0 | -$3.60 | -$3.60 | -$3.60 |
| Q4 2024 | 0 | -$3.20 | -$3.20 | -$3.20 |
vTv Therapeutics Inc. Earnings Date And Information
vTv Therapeutics Inc. last posted its earnings results on Friday, August 11th, 2023. The company reported $-2.8 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $2.73. The company had revenue of 0 for the quarter and had revenue of 0 for the year. vTv Therapeutics Inc. has generated $-10 earnings per share over the last year ($-9.71 diluted earnings per share) and currently has a price-to-earnings ratio of -4.49. vTv Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
vTv Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$0.81 | $0 | $0 | ||
| 05/09/2024 | Q1 2024 | -$1.17 | $1.00 M | $1.00 M | ||
| 03/13/2024 | Q4 2023 | -$1.67 | $0 | $-9,000 | ||
| 11/09/2023 | Q3 2023 | -$3.27 | $0 | |||
| 08/11/2023 | Q2 2023 | -$0.07 | -$2.76 | -2.69 | $9,000 | |
| 05/11/2023 | Q1 2023 | -$3.20 | -$2.21 | 0.99 | $0 | |
| 03/06/2023 | Q4 2022 | -$2.40 | -$2.89 | -0.49 | $3.09 M | $9,000 |
| 11/10/2022 | Q3 2022 | -$2.00 | -$2.12 | -0.12 | $250,000 | $0 |
| 08/15/2022 | Q2 2022 | -$4.00 | -$1.79 | 2.21 | $9,000 | |
| 05/12/2022 | Q1 2022 | -$3.20 | -$5.63 | -2.43 | $2.00 M | |
| 03/29/2022 | Q4 2021 | -$3.20 | -$4.22 | -1.02 | $500,000 | $9,000 |
| 11/09/2021 | Q3 2021 | -$2.80 | -$0.71 | 2.09 | $1.30 M | $3.00 M |
| 08/04/2021 | Q2 2021 | -$2.80 | -$0.41 | 2.39 | $1.00 M | $9,000 |
| 05/05/2021 | Q1 2021 | -$2.40 | -$3.00 | -0.6 | $987,000 | |
| 02/24/2021 | Q4 2020 | -$2.40 | $0.88 | 3.28 | $3.30 M | $6.40 M |
| 11/05/2020 | Q3 2020 | -$4.40 | -$1.27 | 3.13 | $21,000 | $7,000 |
| 08/03/2020 | Q2 2020 | -$4.00 | -$2.95 | 1.05 | $10,285 | $0 |
| 05/07/2020 | Q1 2020 | -$4.00 | -$4.35 | -0.35 | $8,000 | |
| 02/20/2020 | Q4 2019 | -$4.64 | $1.26 M | $7,000 | ||
| 10/30/2019 | Q3 2019 | -$4.40 | -$4.49 | -0.09 | $1.69 M | $8,000 |
vTv Therapeutics Inc. Earnings: Frequently Asked Questions
-
When is vTv Therapeutics Inc.'s earnings date?
vTv Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to vTv Therapeutics Inc.'s earnings conference call?
The conference call for vTv Therapeutics Inc.'s latest earnings report can be listened to online.
-
How can I read vTv Therapeutics Inc.'s conference call transcript?
The conference call transcript for vTv Therapeutics Inc.'s latest earnings report can be read online.
-
How much profit does vTv Therapeutics Inc. generate each year?
vTv Therapeutics Inc. (:VTVT) has a recorded net income of $0. vTv Therapeutics Inc. has generated $-9.71 earnings per share over the last four quarters.
-
What is vTv Therapeutics Inc.'s price-to-earnings ratio?
vTv Therapeutics Inc. (:VTVT) has a price-to-earnings ratio of -4.49 and price/earnings-to-growth ratio is -0.17.
